Total trials
193
Active
16
Phase 3
19
Total enrollment
42,689
Pipeline matrix
Showing 10 of 10 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Naxitamab | — | — | — | — | — | 1 | |
| Vyxeos | — | — | — | — | — | 1 | |
| Mylotarg | — | — | — | — | — | 1 | |
| Chemotherapy Drugs, Cancer | — | — | — | — | — | 1 | |
| Botulinum Toxin A | — | — | — | — | — | 1 | |
| Nafarelin nasal spray | — | — | — | — | — | 1 | |
| Utrogestan® | — | — | — | — | — | 1 | |
| PEG 3350 | — | — | — | — | — | 1 | |
| Risankizumab | — | — | — | — | — | 1 | |
| Budesonide intervention | — | — | — | — | — | 1 |
Next readouts
- 2021-04-15
- 2026-10
- 2027-03
- 2027-07-01
- 2028-06
- 2028-09-07
- 2029-05-01
- 2030-09
Top conditions
- Patent Ductus Arteriosus7
- Cerebral Palsy6
- Pregnancy4
- Gaucher Disease, Type 14
- Inflammatory Bowel Diseases4
- Crohn's Disease4
- Infertility4
- ADHD4
Frequently asked questions about Shaare Zedek Medical Center
- How many clinical trials does Shaare Zedek Medical Center have on ClinicalTrials.gov?
- Shaare Zedek Medical Center is listed as the lead sponsor on 193 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Shaare Zedek Medical Center's trials are in Phase 3?
- 19 of Shaare Zedek Medical Center's trials are in Phase 3, spread across 10 active drug programs.
- What therapeutic areas does Shaare Zedek Medical Center focus on?
- Shaare Zedek Medical Center's most-studied conditions on ClinicalTrials.gov are Patent Ductus Arteriosus, Cerebral Palsy, Pregnancy, Gaucher Disease, Type 1, Inflammatory Bowel Diseases.
- When are Shaare Zedek Medical Center's next clinical trial readouts?
- Shaare Zedek Medical Center has 8 upcoming primary-completion readouts tracked here; the soonest is “Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer”, expected around 2021-04-15.